Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10405753 | 0.91 | MGAM (0.46) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL28262928 | 0.87 | MGAM (0.43) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL15187221 | 0.87 | MGAM (0.43) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL10653154 | 0.87 | MGAM (0.43) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL15187255 | 0.87 | MGAM (0.43) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL8057583 | 0.86 | MGAM (0.41) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL15187368 | 0.84 | ALDH1A1 (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL1456370 | 0.83 | MGAM (0.52) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL234553 | 0.83 | MGAM (0.52) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL28738644 | 0.82 | ALDH1A1 (0.48) | MGAMGAASIMGAM2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119638969-A | Degradable aromatic polyester polymer and synthesis method thereof | 青岛大学 | 2025-03-18 | — | — | CN | claimed |
| CN-100400567-C | Method for producing polyetherols | BASF AG (DE) | 2008-07-09 | — | — | CN | claimed |
| US-7241914-B2 | Method for producing polyesterpolyols of polyvalent alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-10 | — | — | US | claimed |
| CN-1656147-A | Method for producing polyetherols | BASF AG (DE) | 2005-08-17 | — | — | CN | claimed |
| US-20050148802-A1 | Method for producing polyetherols | BASF AKTIENGESELLSCHAFT | 2005-07-07 | — | — | US | claimed |
| CN-1585736-A | Method for producing (meth)acrylic acid esters of polyhydric alcohols | BASF AG (DE) | 2005-02-23 | — | — | CN | claimed |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-13 | — | — | US | claimed |
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | disclosed |
| US-12539332-B2 | Anti-viral and hepatic-targeted drugs | A-BIOPHARMA (FR) | 2026-02-03 | — | — | US | disclosed |
| CN-119638969-A | Degradable aromatic polyester polymer and synthesis method thereof | 青岛大学 | 2025-03-18 | — | — | CN | disclosed |
| US-20240139325-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2024-05-02 | — | — | US | disclosed |
| CN-117567440-A | Synthesis method of cholinergic receptor agonist | 南京恒道医药科技股份有限公司 | 2024-02-20 | — | — | CN | disclosed |
| EP-4045504-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | Ai-biopharma (FR) | 2022-08-24 | — | — | EP | disclosed |
| CN-1656140-A | Method for producing polyesterpolyols of polyvalent alcohols | BASF AG (DE) | 2005-08-17 | — | — | CN | disclosed |
| CN-1656147-A | Method for producing polyetherols | BASF AG (DE) | 2005-08-17 | — | — | CN | disclosed |
| US-20050176910-A1 | Method for the production of esters of polyalcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-11 | — | — | US | disclosed |
| US-20050148802-A1 | Method for producing polyetherols | BASF AKTIENGESELLSCHAFT | 2005-07-07 | — | — | US | disclosed |
| CN-1585736-A | Method for producing (meth)acrylic acid esters of polyhydric alcohols | BASF AG (DE) | 2005-02-23 | — | — | CN | disclosed |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-13 | — | — | US | disclosed |
| US-5576407-A | Copolymers of hydroxyalkyl vinyl ethers for use in detergents and cleaning agents | BASF AKTIENGESELLSCHAFT (DE) | 1996-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12539332-B2 | Anti-viral and hepatic-targeted drugs | HAVCR2, NR1H4, NR1H3 | MGAM 4858/4885GAA 3696/4885SI 4431/4885 |
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | HAVCR2, NR1H4, NR1H3 | MGAM 4855/4885GAA 3250/4885SI 4180/4885 |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | ADH1A, ADH1C, ADH5 | MGAM 242/4885GAA 1528/4885SI 824/4885 |
| US-20050148802-A1 | Method for producing polyetherols | ADH1A, ADH1C, ADH5 | MGAM 924/4885GAA 3686/4885SI 544/4885 |
| US-20240139325-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | SLC10A1, HAVCR2, HDGF | MGAM 4033/4885GAA 187/4885SI 460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.